CONMED Debt to Equity Ratio 2010-2024 | CNMD

Current and historical debt to equity ratio values for CONMED (CNMD) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CONMED debt/equity for the three months ending September 30, 2024 was 1.01.
CONMED Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.00B 0.00
2024-06-30 $1.40B $0.88B 1.59
2024-03-31 $1.46B $0.86B 1.70
2023-12-31 $1.47B $0.83B 1.76
2023-09-30 $1.53B $0.80B 1.92
2023-06-30 $1.54B $0.78B 1.98
2023-03-31 $1.57B $0.75B 2.08
2022-12-31 $1.55B $0.75B 2.08
2022-09-30 $1.58B $0.72B 2.20
2022-06-30 $1.40B $0.67B 2.08
2022-03-31 $1.00B $0.79B 1.26
2021-12-31 $0.98B $0.79B 1.25
2021-09-30 $1.00B $0.76B 1.32
2021-06-30 $1.02B $0.74B 1.37
2021-03-31 $1.02B $0.73B 1.41
2020-12-31 $1.04B $0.71B 1.47
2020-09-30 $1.06B $0.68B 1.55
2020-06-30 $1.05B $0.68B 1.55
2020-03-31 $1.05B $0.70B 1.50
2019-12-31 $1.07B $0.71B 1.50
2019-09-30 $1.06B $0.70B 1.51
2019-06-30 $1.06B $0.70B 1.52
2019-03-31 $1.07B $0.69B 1.54
2018-12-31 $0.71B $0.66B 1.07
2018-09-30 $0.71B $0.65B 1.09
2018-06-30 $0.72B $0.65B 1.10
2018-03-31 $0.71B $0.64B 1.10
2017-12-31 $0.73B $0.63B 1.15
2017-09-30 $0.77B $0.59B 1.31
2017-06-30 $0.75B $0.58B 1.29
2017-03-31 $0.75B $0.58B 1.31
2016-12-31 $0.75B $0.58B 1.29
2016-09-30 $0.75B $0.58B 1.28
2016-06-30 $0.76B $0.58B 1.31
2016-03-31 $0.76B $0.58B 1.31
2015-12-31 $0.52B $0.59B 0.88
2015-09-30 $0.52B $0.58B 0.90
2015-06-30 $0.51B $0.58B 0.88
2015-03-31 $0.51B $0.57B 0.90
2014-12-31 $0.52B $0.58B 0.89
2014-09-30 $0.52B $0.59B 0.87
2014-06-30 $0.50B $0.60B 0.82
2014-03-31 $0.49B $0.60B 0.82
2013-12-31 $0.48B $0.61B 0.80
2013-09-30 $0.49B $0.59B 0.83
2013-06-30 $0.50B $0.59B 0.85
2013-03-31 $0.49B $0.60B 0.81
2012-12-31 $0.47B $0.61B 0.78
2012-09-30 $0.49B $0.60B 0.81
2012-06-30 $0.47B $0.59B 0.79
2012-03-31 $0.49B $0.59B 0.84
2011-12-31 $0.36B $0.57B 0.63
2011-09-30 $0.39B $0.61B 0.64
2011-06-30 $0.38B $0.62B 0.62
2011-03-31 $0.39B $0.60B 0.65
2010-12-31 $0.40B $0.59B 0.68
2010-09-30 $0.42B $0.58B 0.73
2010-06-30 $0.41B $0.58B 0.71
2010-03-31 $0.41B $0.58B 0.70
2009-12-31 $0.38B $0.58B 0.66
2009-09-30 $0.38B $0.57B 0.67
2009-06-30 $0.37B $0.56B 0.65
2009-03-31 $0.37B $0.56B 0.67
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.337B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95